mRNA Therapeutics Market Size, Share & Industry Analysis, By Type (Prophylactic (Vaccines) {COVID-19 Vaccines, Non-COVID-19 Vaccines} and Drugs/Medications), By Application (Oncology, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113411

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 19.9% from 2025-2032
Unit	Value (USD billion)
Segmentation	By Type Prophylactic (Vaccines) COVID-19 Vaccines Non-COVID-19 Vaccines Drugs/Medications By Application Oncology Infectious Diseases Others By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Others By Region North America (By Type, Application, Distribution Channel, and Country) U.S. Canada Europe (By Type, Application, Distribution Channel, and Country/Sub-Region) Germany U.K. France Italy Spain Rest of Europe Asia Pacific (By Type, Application, Distribution Channel, and Country/Sub-Region) China Japan India Australia Southeast Asia Rest of the Asia Pacific Rest of the World (By Type, Application, Distribution Channel)